Journal
JOURNAL OF BIOMOLECULAR SCREENING
Volume 9, Issue 6, Pages 533-540Publisher
SAGE PUBLICATIONS INC
DOI: 10.1177/1087057104264902
Keywords
PXR; transactivation assay; binding assay; HTS
Ask authors/readers for more resources
Pregnane X receptor (PXR) transactivation and binding assays have been developed into high-throughput assays, which are robust and reproducible (Z' > 0.5). For most compounds, there was a good correlation between the results of the transactivation and binding assays. EC50 values of compounds in the transactivation assay correlated reasonably well with their IC50 values in the binding assay. However, there were discrepancies with some compounds showing high binding affinity in the binding assay translated into low transactivation. The most likely cause for these discrepancies was an agonist-dependent relationship between binding affinity and transactivation response. In general, compounds that bound to human PXR and transactivated PXR tended to be large hydrophobic molecules.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available